| Alisha Shelton, | |
|
225 South Bluff Street, Winnebago, NE 68071 | |
| (402) 878-2911 | |
| Not Available |
| Full Name | Alisha Shelton |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 225 South Bluff Street, Winnebago, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518249846 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 1203 (Nebraska) | Primary |
| 101YP2500X | Counselor - Professional | 2114 (Nebraska) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Alisha Shelton, Po Box 446, Winnebago, NE 68071-0446 Ph: (402) 878-2911 | Alisha Shelton, 225 South Bluff Street, Winnebago, NE 68071 Ph: (402) 878-2911 |
News Archive
The University of Illinois Hospital & Health Sciences System will begin a survey this month to identify the unique healthcare needs of the communities it serves - from Humbolt Park and West Town in the north, to West Lawn and Englewood in the southern corners.
Researchers in the Netherlands assessed the quality of colonoscopy reporting in daily clinical practice and evaluated the quality of colonoscopy performance. They found that colonoscopy reporting varied significantly in clinical practice.
To detect "silent" or new cardiac abnormalities, all patients hospitalized for stroke should receive continuous cardiac rhythm monitoring (telemetry) for at least the first 24 hours after the stroke is detected, according to a Loyola University Health System study presented at the American Stroke Association's International Stroke Conference 2006.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin proteins to treat cancer and fibrosis, today announced that the Japan Patent Office has accepted a new patent, No. 2002-574987, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer". The patent protects, among other things, methods for reducing the toxicity of chemotherapies in which a polysaccharide, such as the Company's lead drug DAVANAT®, is co-administered with a chemotherapeutic agent to reduce toxicity of the chemotherapy.
› Verified 9 days ago
Jillian Angeline Kelsey-berridge, BS, PLADC Counselor Medicare: Not Enrolled in Medicare Practice Location: Hwy 77/75, Winnebago, NE 68071 Phone: 402-878-2480 Fax: 402-878-2204 | |
Mr. Todd Daniel Baier, PLMHP, PLADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 100 Bluff Ave, Winnebago, NE 68071 Phone: 402-878-2911 | |
Lacee Murtaugh, PLMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 100 Bluff Ave, Winnebago, NE 68071 Phone: 402-878-2911 Fax: 402-878-2027 | |
Angela Rebecca Mcelmuray Dundee, PLMHP, PMSW, LSMW Counselor Medicare: Not Enrolled in Medicare Practice Location: Augustine Dr #2, Winnebago, NE 68071 Phone: 402-878-2046 Fax: 402-878-2065 | |
Karen Ann Oaks, LMHP, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: Hwy 77/75, Ihs Hospital, Winnebago, NE 68071 Phone: 402-878-2911 Fax: 402-878-2027 | |
Bobbi Jo Van Lent, PLADC Counselor Medicare: Not Enrolled in Medicare Practice Location: Po Box A, Winnebago, NE 68071 Phone: 402-878-2480 Fax: 402-878-2204 | |
Gwendolyn Porter, Counselor Medicare: Not Enrolled in Medicare Practice Location: Augustine Dr. #2, Winnebago, NE 68071 Phone: 402-878-2046 |